The pathogenesis of inflammatory muscle diseases: On the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis

Autoimmunity Reviews

Volumn 1, Issue 4, 2002, Pages 226-232

  Pignone, Alberto ^a   Fiori, Ginevra ^a   Del Rosso, Angela ^a   Generini, Sergio ^a   Matucci Cerinic, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Apoptosis; Dermatomyositis; Inflammatory muscle diseases; Polymyositis

Indexed keywords

APOPTOSIS; CELL INFILTRATION; CELLULAR IMMUNITY; CYTOTOXICITY; DERMATOMYOSITIS; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; LYMPHOCYTE; MUSCLE CELL; MUSCULAR DYSTROPHY; MYOSITIS; NEUROMUSCULAR DISEASE; PATHOGENESIS; POLYMYOSITIS; REVIEW; SKELETAL MUSCLE; ENVIRONMENT; GENETICS; IMMUNOLOGY; PATHOLOGY; RISK FACTOR;

APOPTOSIS; DERMATOMYOSITIS; ENVIRONMENT; HUMANS; MUSCLE FIBERS; POLYMYOSITIS; RISK FACTORS;

EID: 0041467403     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(02)00055-1     Document Type: Review

References (39)

1. Marrack P., Kappler J., Kotzin B.L. Autoimmune disease: why and where it occurs. Nat Med. 7:2001;899-905.
2. Shamim E.A., Miller F.W. Familial autoimmunity and the idiopathic inflammatory myopathies. Curr Rheumatol Rep. 2:2000;201-211.
3. Griffiths M.M., Encinas G.A., Remmers E.F., Kuchroo V.K., Wilder R.L. Mapping autoimmunity genes. Curr Opin Immunol. 11:1999;689-700.
4. Encinas J.A., Kuchroo V.K. Mapping and identification of autoimmunity genes. Curr Opin Immunol. 12:2000;691-697.
5. Garlepp M.J. Genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol. 8:1996;514-520.
6. Arnett F.C., Targoff I.N., Mimori T., Goldstein R., Warner N.B., Reveille J.D. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum. 39:1996;1507-1518.
7. Leff R.L., Burgess S.H., Miller F.W., et al. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo and anti-signal recognition particle autoantibodies. Artrithis Rheum. 34:1991;1391-1396.
8. Travers R.L., Hughes G.R., Sewall J.R. Coxsackie B neutralization titers in polymyositis/dermatomyositis. Lancet. 1:1977;1268.
9. Schiraldi O., Iandolo E. Polymyositis accompanying Coxsackie virus B infection. Infection. 6:1978;32-34.
10. Tam P.E., Schmidt A.M., Ytterberg S.R., Messner R.P. Viral persistence during the developmental phase of Coxsackie virus B1-induced murine polymyositis. J Virol. 65:1991;6654-6660.
11. Tam P.E., Schmidt A.M., Ytterberg S.R., Messner R.P. Duration of virus persistence and its relationship to inflammation during the chronic phase of Coxsackie virus B1-induced murine polymyositis. J Lab Clin Med. 123:1994;346-356.
12. Arahata K., Engel A.G. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol. 16:1984;193-208.
13. Engel A.G., Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol. 16:1984;209-215.
14. Mantegazza R., Bernasconi P., Confalonieri P., Cornelio F. Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features. J Neurol. 244:1997;277-287.
15. Hohlfeld R., Engel A.G., Goebles N., Behrens L. Cellular immune mechanism in inflammatory myopathies. Curr Opin Rheumatol. 9:1997;520-526.
16. Yagita H., Hanabuchi S., Asano Y., Tamura T., Nariuchi H., Okumura K. Fas-mediated cytotoxicity - a new immunoregulatory and pathogenic function of Th1 CD4+ cells. Immunol Rev. 146:1995;223-239.
17. Sugiura T., Murakawa Y., Nagai A., Kondo M., Kobayashi S. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies. CD4+ T cells cause muscle cell injury directly in polymyositis. Arthritis Rheum. 42:1999;291-298.
18. Kikuchi Y., Koarada S., Toda Y., et al. Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RPI05 on peripheral blood B cells. Ann Rheum Dis. 60:2001;1137-1140.
19. Emslie-Smith A.M., Engel A.G. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol. 27:1990;343-356.
20. De Bleeker J.L., Engel A.G. Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy. J Neuropathol Exp Neurol. 53:1994;369-376.
21. Cid M.C., Grau J.M., Casademont J., et al. Leukocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (idiopathic inflammatory myopathy). Clin Exp Immunol. 104:1996;467-473.
22. O'Hanlon T.P., Miller F.W. T cell-mediated immune mechanism in myositis. Curr Opin Rheumatol. 7:1995;503-509.
23. Lundberg I., Ulfgren A.K., Nyberg P., Andersson U., Klareskog L. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40:1997;865-874.
24. Confalonieri P., Bernasconi P., Cornelio F., Mantegazza R. Trasforming growth factor-1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. J Neuropathol Exp Neurol. 56:1997;479-484.
25. Tews D.S., Goebel H.H. Cytokine expression profile in idiopathic inflammatory myopathies. J Neuropathol Exp Neurol. 55:1996;342-347.
26. Lundberg I., Kratz A.H., Alexanderson H., Patarroyo M. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum. 43:(2):2000;336-348.
27. Schwartz S.M., Bennet M.R. Death by any author name. Am J Pathol. 147:1995;229-234.
28. Dalakas M.E. Polymiositis, dermatomyositis and inclusion body myositis. N Engl J Med. 325:1991;1487-1498.
29. Mountz J.D., Wu J., Cheng J., Zhou T. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum. 37:1994;1415-1420.
30. Waldner H., Sobel R.A., Howard E., Kuchroo V.K. Fas and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J Immunol. 159:1997;3100-3103.
31. Inukai A., Kobayashi Y., Honda H., Sobue G. Fas antigen is expressed in human diseased muscles, but does not link to apoptosis. Nippon Rinsho. 54:1996;1992-1996.
32. Sugiura T., Murakawa Y., Nagai A., Kondo M., Kobayashi S. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies. Arthritis Rheum. 42:1999;291-298.
33. Schneider C., Gold R., Dalakas M.C., et al. MHC class-I mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, and inclusion body myositis. J Neuropathol Exp Neurol. 55:1996;1205-1209.
34. Falcini F., Calzolari A., Generini S., et al. Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. Clin Exp Rheumatol. 18:2000;643-646.
35. Nagaraju K., Casciola-Rosen L., Rosen A., et al. The inhibition of apoptosis in myositis and normal muscle cells. J Immunol. 164:2000;5459-5465.
36. Li M., Dalakas M.C. Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell-mediated inflammatory myopathies. J Neuroimmunol. 106:2000;1-5.
37. Vattemi G., Tonin P., Filosto M., Spagnolo M., Rizzuto N., Tomelleri G. T-cell anti-apoptotic mechanism in inflammatory myopathies. J Neuroimmunol. 111:2000;146-151.
38. Rosen A., Casciola-Rosen I. Autoantigens as substrates for apoptotic process: implication for the pathogenesis of systemic autoimmune disease. Cell Death Differentiation. 6:1999;6-12.
39. Chang-Chirgh, Ahearn J.M. Skeletal muscle cells and the pathogenesis of myositis: a prospective. Curr Rheumatol Rep. 3:2001;325-333.